|
Department Memorandum 2022-0033 |
January 26, 2022 |
Guidelines on the use of self-administered antigen testing for COVID-19 |
|
Department Memorandum 2022-0041 |
January 24, 2022 |
Interim guidelines on the management and administration of Tozinameran COVID-19 mRNA vaccine (nucleoside-modified) [Cominarty] Pfizer COVID-19 vaccine to pediatric population ages 5-11 years old |
|
Joint Memorandum Circular 2022-0001 |
January 20, 2022 |
Operational Guidelines for the Loaning of COVID-19 Vaccine Doses Between the National Government, Local Government Units, and Private Sector Entities |
|
Department Circular 2022-0064 |
January 17, 2022 |
Adjustments in Maximum Retail Price (MRP) regulation of certain medicines that are covered by Executive Order No. 155 pursuant to exemption from Value Added Tax (VAT) |
|
Department Memorandum 2022-0013 |
January 14, 2022 |
Updated Guidelines on Quarantine, Isolation, and Testing for COVID-19 Response and Case Management for the Omicron Variant |
|
Joint Memorandum Circular No. 22-01 |
January 10, 2022 |
Setting of purchase limit/cap for Paracetamol, Phenylephrinehydochloride, Carbocisteine, and Chlorphenamine Maleate Paracetamol |
|
Department Circular 2022-0002 |
January 06, 2022 |
Advisory on COVID-19 Protocols for Quarantine and Isolation |
|
Department Memorandum 2021-0492-A |
December 01, 2021 |
Amendment to DM No. 2021-0492: Interim Guidelines on the Administration and Management of COVID-19 Vaccine Booster/Additional Doses to Priority Group A2: Senior Citizens ages 60 years old & above and Priority Group A3... |
|
Department Memorandum 2021-0492 |
November 19, 2021 |
Interim Guidelines on the Administration and Management of COVID-19 Vaccine Booster/ Additional Doses to Priority Group A2: Senior Citizen ages 60 years old and above and Priority A3: Adults with Comorbidities |
|
Department Circular 2021-0525 |
November 16, 2021 |
Reiteration of the Interim Operational Guidelines on the Administration of COVID-19 Vaccine Booster Dose to Priority Group A1: Essential Workers in Frontline Health Services (A1.1 to A1.7) |
|
Department Circular 2021-0464 |
October 14, 2021 |
Interim Operational Guidelines on the COVID-19 Vaccination of the Pediatric Population Ages 12-17 Years Old with Comorbidities |
|
Joint Memorandum Circular 2021-0001-A |
September 23, 2021 |
Amendment of Joint Memorandum Circular of DOH-DTI-DOLE-DILG-DOTr-PSC-GAB entitled "Clarificatory Guidelines on the Mandatory Use of Face Shields Outside of Residence for COVID-19 Mitigation" |
